Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MenACWY-CRM (Menveo) in healthy subjects 11-55 years in Korea
NCT01274897Phase 3Completed
- Sponsor
- Novartis
- Start
- Dec 2010
- Primary completion
- Mar 2011
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen in meningococcal disease, meningococcal meningitis, sponsored by Novartis. Started Dec 2010; status: completed.
02
Drugs
neisseria meningitidis group a capsular oligosaccharide diphtheria crm197 protein conjugate antigen
03
Conditions
meningococcal diseasemeningococcal meningitis
Beyond the preview
Go deeper on NCT01274897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01274897.